Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 7/20 | 0.48 |
| ▸ | PIK3CA | P42336 | 10/20 | 0.43 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.41 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869711 | 0.92 | PRKCQ (0.45) | PIK3CGKDM1APIK3CAPIK3CBMTOR | |
| SCHEMBL30869587 | 0.90 | PIK3CG (0.41) | PIK3CGKDM1APIK3CAPIK3CBMTOR | |
| SCHEMBL30869729 | 0.84 | PIK3CG (0.48) | PIK3CGPIK3CAPIK3CBMTORMETAP2 | |
| SCHEMBL30869650 | 0.83 | PIK3CD (0.47) | KDM1APIK3CAPIK3CBPIK3CD | |
| SCHEMBL30869713 | 0.82 | PIK3CA (0.36) | PIK3CGKDM1APIK3CAPIK3CDPIK3R1 | |
| SCHEMBL32682887 | 0.81 | EGFR (0.52) | KDM1APIK3CA | |
| SCHEMBL30869697 | 0.78 | BRAF (0.42) | METAP2 | |
| SCHEMBL30869717 | 0.77 | PIK3CG (0.41) | PIK3CGKDM1APIK3CAMTORMETAP2 | |
| SCHEMBL32682882 | 0.76 | KDM1A (0.47) | KDM1A | |
| SCHEMBL30869758 | 0.76 | KDM1A (0.47) | KDM1APIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4583868-A2 | DYNAMIN ACTIVATORS | Walden Biosciences, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054661-A2 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES (US) | 2024-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | DNM1, DNM1L, DNM2 | PIK3CG 159/4885KDM1A 3264/4885PIK3CA 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.